Allergy/Asthma News

School-aged children residing in historically redlined neighborhoods had higher exposures to pollutants and worse asthma severity, according to a study in The Journal of Allergy and Clinical Immunology.

On June 28, the U.S. Supreme Court ruled 6-3 in Loper Bright Enterprises v. Raimondo, Secretary of Commerce to overturn a decades-old decision known as the “Chevron deference.”

SAN ANTONIO — Climate change is making allergies and asthma worse, but patient education and professional advocacy may mitigate these impacts, Jeffrey Demain, MD, FAAAAI, FACAAI, FAAP, told Healio.

A recent study published in the European Journal of Allergy and Clinical Immunology shows that significant cross-reactivity may exist between lupin and other legumes.

SAN ANTONIO — Career development as well as continuing education and connections are among the goals of the Association of PAs in Allergy, Asthma & Immunology, according to incoming president Heather O’Connell, PA-C.

RSV infections contribute to the burden and severity of COVID-19, increasing susceptibility and chance for hospitalizations, according to a study published in the European Journal of Allergy and Clinical Immunology.

Cendakimab was effective and generally safe in the treatment of moderate to severe atopic dermatitis in adults, according to a press release.

A novel peptide that uniquely affects the effector and regulatory arms of immune responses has potential for treating eosinophilic esophagitis and other allergic diseases, according to a press release from Revolo Biotherapeutics.

The Federal Trade Commission proposal to ban noncompete clauses for all workers has sent powerful ripples through the health care industry, prompting physicians of all specialties to reevaluate their career trajectories.

Omalizumab is effective and safe for the treatment of chronic urticaria, demonstrating high discontinuation due to well-controlled disease, according to a study.